Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Carcinoma of the Anal Canal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02437851
What this trial is testing

Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

Who this might be right for
Anal Squamous Cell CarcinomaHIV InfectionStage 0 Anal Canal Cancer+1 more
AIDS Malignancy Consortium 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07800000
What this trial is testing

Becotatug Vedotin Plus Pucotenlimab and Capecitabine Followed by Concurrent Chemoradiotherapy-Immunotherapy for Locally Advanced Squamous Cell Carcinoma of the Anal Canal

Who this might be right for
Squamous Cell Carcinoma of the Anal Canal
Wang Xin 34
Testing effectiveness (Phase 2)Looking for participantsNCT05661188
What this trial is testing

Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS)

Who this might be right for
Squamous Cell Carcinoma of the Anal Canal
Grupo Espanol Multidisciplinario del Cancer Digestivo 45
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Early research (Phase 1)Study completedNCT04580485
What this trial is testing

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

Who this might be right for
Ovarian CancerBladder CancerNon Small Cell Lung Cancer+8 more
Incyte Corporation 54
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT03357757
What this trial is testing

Avelumab With Valproic Acid in Virus-associated Cancer

Who this might be right for
Cancer That is Associated With a Chronic Viral Infectionp16 Positive SCCHNSquamous Cell Carcinoma of the Cervix+5 more
AHS Cancer Control Alberta 39
Testing effectiveness (Phase 2)Study completedNCT02402842
What this trial is testing

Clinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal Carcinoma

Who this might be right for
Anal Canal Carcinoma
Centre Hospitalier Universitaire de Besancon 70
Testing effectiveness (Phase 2)Study completedNCT02399813
What this trial is testing

Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal

Who this might be right for
Anal CancerRectal Cancer
Advaxis, Inc. 36
Large-scale testing (Phase 3)Study completedNCT00025090
What this trial is testing

Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer

Who this might be right for
Anal Cancer
University College London (UCL) Cancer Institute 600
Testing effectiveness (Phase 2)Study completedNCT01941966
What this trial is testing

Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal.

Who this might be right for
Anal Canal Cancer.
Instituto do Cancer do Estado de São Paulo 51
Testing effectiveness (Phase 2)Study completedNCT00324415
What this trial is testing

Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer

Who this might be right for
Anal Cancer
AIDS Malignancy Consortium 45
Testing effectiveness (Phase 2)Ended earlyNCT01382745
What this trial is testing

Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers

Who this might be right for
Squamous Cell Carcinoma of Anal Canal
Dr. Te Vuong 1
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT02314169
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer

Who this might be right for
Anal Canal Squamous Cell CarcinomaMetastatic Anal Canal CarcinomaStage IV Anal Cancer AJCC v8
National Cancer Institute (NCI) 143
Not applicableLooking for participantsNCT07455942
What this trial is testing

Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer

Who this might be right for
Squamous Cell Carcinoma of the Anal CanalHPV-induced Cancer
Centre Hospitalier Intercommunal Creteil 300
Large-scale testing (Phase 3)Study completedNCT04472429
What this trial is testing

Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

Who this might be right for
Squamous Cell Carcinoma of the Anal Canal
Incyte Corporation 308
Not applicableAvailableNCT06910137
What this trial is testing

An Early Access Program Guideline to Provide Access to Retifanlimab (INCMGA00012) Together With Carboplatin and Paclitaxel for Squamous Carcinoma of the Anal Canal (SCAC)

Who this might be right for
Squamous Cell Carcinoma of the Anal Canal
Incyte Corporation
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT00316888
What this trial is testing

Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer

Who this might be right for
Anal Cancer
ECOG-ACRIN Cancer Research Group 63
Next Page